Oil & Gas Equipment & Services
Compare Stocks
5 / 10Stock Comparison
OII vs TDW vs CLOV vs ACDC vs NESR
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Equipment & Services
Medical - Healthcare Plans
Oil & Gas Equipment & Services
Oil & Gas Equipment & Services
OII vs TDW vs CLOV vs ACDC vs NESR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Equipment & Services | Oil & Gas Equipment & Services | Medical - Healthcare Plans | Oil & Gas Equipment & Services | Oil & Gas Equipment & Services |
| Market Cap | $3.65B | $3.87B | $1.44B | $1.19B | $2.24B |
| Revenue (TTM) | $2.80B | $1.35B | $2.21B | $1.94B | $1.27B |
| Net Income (TTM) | $339M | $298M | $-57M | $-367M | $70M |
| Gross Margin | 20.0% | 22.4% | 42.5% | 3.7% | 13.9% |
| Operating Margin | 10.3% | 20.0% | -2.6% | -8.5% | 8.8% |
| Forward P/E | 20.5x | 19.8x | 65.9x | — | 15.3x |
| Total Debt | $487M | $655M | $0.00 | $1.14B | $409M |
| Cash & Equiv. | $689M | $579M | $78M | $23M | $108M |
OII vs TDW vs CLOV vs ACDC vs NESR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 22 | May 26 | Return |
|---|---|---|---|
| Oceaneering Interna… (OII) | 100 | 287.6 | +187.6% |
| Tidewater Inc. (TDW) | 100 | 305.9 | +205.9% |
| Clover Health Inves… (CLOV) | 100 | 105.6 | +5.6% |
| ProFrac Holding Cor… (ACDC) | 100 | 36.1 | -63.9% |
| National Energy Ser… (NESR) | 100 | 313.0 | +213.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: OII vs TDW vs CLOV vs ACDC vs NESR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
OII lags the leaders in this set but could rank higher in a more targeted comparison.
TDW carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.74, Low D/E 48.1%, current ratio 2.90x
- Beta 0.74, current ratio 2.90x
- 22.2% margin vs ACDC's -18.9%
- Beta 0.74 vs CLOV's 1.22
CLOV ranks third and is worth considering specifically for growth.
- 40.3% revenue growth vs ACDC's -11.4%
Among these 5 stocks, ACDC doesn't own a clear edge in any measured category.
NESR is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 1 yrs, beta 1.18
- Rev growth 13.6%, EPS growth 5.2%, 3Y rev CAGR 14.1%
- 145.5% 10Y total return vs OII's 16.7%
- Better valuation composite
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 40.3% revenue growth vs ACDC's -11.4% | |
| Value | Better valuation composite | |
| Quality / Margins | 22.2% margin vs ACDC's -18.9% | |
| Stability / Safety | Beta 0.74 vs CLOV's 1.22 | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +286.0% vs CLOV's -25.2% | |
| Efficiency (ROA) | 13.4% ROA vs ACDC's -13.1%, ROIC 15.2% vs -4.6% |
OII vs TDW vs CLOV vs ACDC vs NESR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
OII vs TDW vs CLOV vs ACDC vs NESR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NESR leads in 2 of 6 categories
TDW leads 1 • OII leads 1 • CLOV leads 0 • ACDC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TDW leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
OII is the larger business by revenue, generating $2.8B annually — 2.2x NESR's $1.3B. TDW is the more profitable business, keeping 22.2% of every revenue dollar as net income compared to ACDC's -18.9%. On growth, CLOV holds the edge at +62.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.8B | $1.3B | $2.2B | $1.9B | $1.3B |
| EBITDAEarnings before interest/tax | $394M | $477M | -$55M | $251M | $257M |
| Net IncomeAfter-tax profit | $339M | $298M | -$57M | -$367M | $70M |
| Free Cash FlowCash after capex | $240M | $282M | $55M | $20M | $46M |
| Gross MarginGross profit ÷ Revenue | +20.0% | +22.4% | +42.5% | +3.7% | +13.9% |
| Operating MarginEBIT ÷ Revenue | +10.3% | +20.0% | -2.6% | -8.5% | +8.8% |
| Net MarginNet income ÷ Revenue | +12.1% | +22.2% | -2.6% | -18.9% | +5.5% |
| FCF MarginFCF ÷ Revenue | +8.6% | +20.9% | +2.5% | +1.0% | +3.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.7% | -2.2% | +62.0% | -4.0% | -12.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -26.5% | -85.5% | — | -33.3% | -18.2% |
Valuation Metrics
Evenly matched — TDW and ACDC each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 10.5x trailing earnings, OII trades at a 64% valuation discount to NESR's 29.2x P/E. On an enterprise value basis, TDW's 7.1x EV/EBITDA is more attractive than NESR's 9.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.6B | $3.9B | $1.4B | $1.2B | $2.2B |
| Enterprise ValueMkt cap + debt − cash | $3.4B | $3.9B | $1.4B | $2.3B | $2.5B |
| Trailing P/EPrice ÷ TTM EPS | 10.48x | 11.73x | -16.59x | -2.86x | 29.19x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.47x | 19.79x | 65.89x | — | 15.31x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 2.39x |
| EV / EBITDAEnterprise value multiple | 8.47x | 7.15x | — | 8.19x | 9.07x |
| Price / SalesMarket cap ÷ Revenue | 1.31x | 2.86x | 0.75x | 0.61x | 1.72x |
| Price / BookPrice ÷ Book value/share | 3.44x | 2.86x | 4.72x | 1.20x | 2.46x |
| Price / FCFMarket cap ÷ FCF | 17.55x | 10.96x | — | 60.74x | 18.05x |
Profitability & Efficiency
OII leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
OII delivers a 34.3% return on equity — every $100 of shareholder capital generates $34 in annual profit, vs $-38 for ACDC. NESR carries lower financial leverage with a 0.45x debt-to-equity ratio, signaling a more conservative balance sheet compared to ACDC's 1.30x. On the Piotroski fundamental quality scale (0–9), TDW scores 8/9 vs CLOV's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +34.3% | +23.8% | -17.1% | -38.2% | +7.3% |
| ROA (TTM)Return on assets | +13.3% | +13.4% | -9.6% | -13.1% | +3.9% |
| ROICReturn on invested capital | +23.4% | +15.2% | -34.0% | -4.6% | +8.4% |
| ROCEReturn on capital employed | +17.7% | +15.2% | -24.5% | -6.2% | +10.9% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 8 | 2 | 3 | 8 |
| Debt / EquityFinancial leverage | 0.45x | 0.48x | — | 1.30x | 0.45x |
| Net DebtTotal debt minus cash | -$201M | $76M | -$78M | $1.1B | $301M |
| Cash & Equiv.Liquid assets | $689M | $579M | $78M | $23M | $108M |
| Total DebtShort + long-term debt | $487M | $655M | $0 | $1.1B | $409M |
| Interest CoverageEBIT ÷ Interest expense | 7.65x | 4.05x | — | -1.22x | 3.17x |
Total Returns (Dividends Reinvested)
NESR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TDW five years ago would be worth $55,614 today (with dividends reinvested), compared to $3,271 for CLOV. Over the past 12 months, NESR leads with a +286.0% total return vs CLOV's -25.2%. The 3-year compound annual growth rate (CAGR) favors NESR at 94.0% vs ACDC's -13.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +47.2% | +49.1% | +17.0% | +62.9% | +47.9% |
| 1-Year ReturnPast 12 months | +99.0% | +97.5% | -25.2% | +55.9% | +286.0% |
| 3-Year ReturnCumulative with dividends | +115.9% | +81.9% | +221.7% | -35.5% | +629.7% |
| 5-Year ReturnCumulative with dividends | +137.5% | +456.1% | -67.3% | -63.7% | +72.6% |
| 10-Year ReturnCumulative with dividends | +16.7% | -67.7% | -72.4% | -63.7% | +145.5% |
| CAGR (3Y)Annualised 3-year return | +29.3% | +22.1% | +47.6% | -13.6% | +94.0% |
Risk & Volatility
Evenly matched — OII and TDW each lead in 1 of 2 comparable metrics.
Risk & Volatility
TDW is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than CLOV's 1.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. OII currently trades 91.2% from its 52-week high vs ACDC's 61.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.06x | 0.74x | 1.22x | 0.83x | 1.18x |
| 52-Week HighHighest price in past year | $40.12 | $93.13 | $3.92 | $10.70 | $26.85 |
| 52-Week LowLowest price in past year | $18.31 | $38.24 | $1.58 | $3.08 | $5.47 |
| % of 52W HighCurrent price vs 52-week peak | +91.2% | +83.6% | +71.9% | +61.5% | +87.0% |
| RSI (14)Momentum oscillator 0–100 | 51.4 | 43.2 | 69.5 | 55.8 | 58.8 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 852K | 5.6M | 1.5M | 2.1M |
Analyst Outlook
NESR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: OII as "Hold", TDW as "Hold", CLOV as "Hold", ACDC as "Hold", NESR as "Buy". Consensus price targets imply 50.3% upside for TDW (target: $117) vs -9.8% for OII (target: $33).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $33.00 | $117.00 | $3.33 | $6.00 | $26.80 |
| # AnalystsCovering analysts | 44 | 26 | 9 | 6 | 6 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 0 | — | — | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.2% | +2.3% | +3.8% | 0.0% | 0.0% |
NESR leads in 2 of 6 categories (Total Returns, Analyst Outlook). TDW leads in 1 (Income & Cash Flow). 2 tied.
OII vs TDW vs CLOV vs ACDC vs NESR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is OII or TDW or CLOV or ACDC or NESR a better buy right now?
For growth investors, Clover Health Investments, Corp.
(CLOV) is the stronger pick with 40. 3% revenue growth year-over-year, versus -11. 4% for ProFrac Holding Corp. (ACDC). Oceaneering International, Inc. (OII) offers the better valuation at 10. 5x trailing P/E (20. 5x forward), making it the more compelling value choice. Analysts rate National Energy Services Reunited Corp. (NESR) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — OII or TDW or CLOV or ACDC or NESR?
On trailing P/E, Oceaneering International, Inc.
(OII) is the cheapest at 10. 5x versus National Energy Services Reunited Corp. at 29. 2x. On forward P/E, National Energy Services Reunited Corp. is actually cheaper at 15. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — OII or TDW or CLOV or ACDC or NESR?
Over the past 5 years, Tidewater Inc.
(TDW) delivered a total return of +456. 1%, compared to -67. 3% for Clover Health Investments, Corp. (CLOV). Over 10 years, the gap is even starker: NESR returned +145. 5% versus CLOV's -72. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — OII or TDW or CLOV or ACDC or NESR?
By beta (market sensitivity over 5 years), Tidewater Inc.
(TDW) is the lower-risk stock at 0. 74β versus Clover Health Investments, Corp. 's 1. 22β — meaning CLOV is approximately 64% more volatile than TDW relative to the S&P 500. On balance sheet safety, National Energy Services Reunited Corp. (NESR) carries a lower debt/equity ratio of 45% versus 130% for ProFrac Holding Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — OII or TDW or CLOV or ACDC or NESR?
By revenue growth (latest reported year), Clover Health Investments, Corp.
(CLOV) is pulling ahead at 40. 3% versus -11. 4% for ProFrac Holding Corp. (ACDC). On earnings-per-share growth, the picture is similar: National Energy Services Reunited Corp. grew EPS 515. 4% year-over-year, compared to -93. 6% for Clover Health Investments, Corp.. Over a 3-year CAGR, TDW leads at 27. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — OII or TDW or CLOV or ACDC or NESR?
Tidewater Inc.
(TDW) is the more profitable company, earning 24. 7% net margin versus -19. 0% for ProFrac Holding Corp. — meaning it keeps 24. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TDW leads at 21. 4% versus -6. 9% for ACDC. At the gross margin level — before operating expenses — TDW leads at 30. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is OII or TDW or CLOV or ACDC or NESR more undervalued right now?
On forward earnings alone, National Energy Services Reunited Corp.
(NESR) trades at 15. 3x forward P/E versus 65. 9x for Clover Health Investments, Corp. — 50. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TDW: 50. 3% to $117. 00.
08Which pays a better dividend — OII or TDW or CLOV or ACDC or NESR?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is OII or TDW or CLOV or ACDC or NESR better for a retirement portfolio?
For long-horizon retirement investors, Tidewater Inc.
(TDW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74)). Both have compounded well over 10 years (TDW: -67. 7%, CLOV: -72. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between OII and TDW and CLOV and ACDC and NESR?
These companies operate in different sectors (OII (Energy) and TDW (Energy) and CLOV (Healthcare) and ACDC (Energy) and NESR (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: OII is a small-cap deep-value stock; TDW is a small-cap deep-value stock; CLOV is a small-cap high-growth stock; ACDC is a small-cap quality compounder stock; NESR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.